본문 바로가기
KERD
논문KCI 등재

Cellular Senescence in Arterial Diseases

Ippei Shimizu|Tohru Minamino
한국지질동맥경화학회 (The Korean Society of Lipidology and Atherosclerosis)|2020.01|지질·동맥경화학회지 (Journal of Lipid and Atherosclerosis)|제9권 제1호|pp. 79-91|DOI 10.12997/jla.2020.9.1.79

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Cellular senescenceArterial diseasesSenolysis

초록

Cell-proliferation potency is limited, as cells cannot proceed through the cell cycle continually. Instead, they eventually show an irreversible arrest of proliferation, commonly referred to as cellular senescence. Following the initial discovery of this phenomenon by Hayflick et al., studies have indicated that cells are also destined to undergo aging. In addition to the irreversible termination of proliferation, senescent cells are characterized by a flattened and enlarged morphology. Senescent cells become pro-inflammatory and contribute to the initiation and maintenance of sustained chronic sterile inflammation. Aging is associated with the accumulation of senescent cells in the cardiovascular system, and in general these cells are considered to be pathogenic because they mediate vascular remodeling. Recently, genetic and pharmacological approaches have enabled researchers to eliminate senescent cells both in vitro and in vivo. The term “senolysis” is now used to refer to the depletion of senescent cells, and evidence indicates that senolysis contributes to the reversal of age-related pathogenic phenotypes without the risk of tumorigenesis. The concept of senolysis has opened new avenues in research on aging, and senolysis may be a promising therapeutic approach for combating age-related disorders, including arterial diseases.

Abstract

Cell-proliferation potency is limited, as cells cannot proceed through the cell cycle continually. Instead, they eventually show an irreversible arrest of proliferation, commonly referred to as cellular senescence. Following the initial discovery of this phenomenon by Hayflick et al., studies have indicated that cells are also destined to undergo aging. In addition to the irreversible termination of proliferation, senescent cells are characterized by a flattened and enlarged morphology. Senescent cells become pro-inflammatory and contribute to the initiation and maintenance of sustained chronic sterile inflammation. Aging is associated with the accumulation of senescent cells in the cardiovascular system, and in general these cells are considered to be pathogenic because they mediate vascular remodeling. Recently, genetic and pharmacological approaches have enabled researchers to eliminate senescent cells both in vitro and in vivo. The term “senolysis” is now used to refer to the depletion of senescent cells, and evidence indicates that senolysis contributes to the reversal of age-related pathogenic phenotypes without the risk of tumorigenesis. The concept of senolysis has opened new avenues in research on aging, and senolysis may be a promising therapeutic approach for combating age-related disorders, including arterial diseases.

참고문헌 (98)

  1. Chien KR, "Longevity and lineages : toward the integrative biology of degenerative diseases in heart, muscle, and bone", Cell, 120, pp.533~544 (2005)
  2. López-Otín C, "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
  3. Lakatta EG, "So! What's aging? Is cardiovascular aging a disease?", J Mol Cell Cardiol, 83, pp.1~13 (2015)
  4. Triposkiadis F, "Cardiovascular aging and heart failure : JACC review topic of the week", J Am Coll Cardiol, 74, pp.804~813 (2019)
  5. Yoshii M, "The relationship between coronary artery disease and parameters of arteriosclerosis in patients with ischemic heart disease", J Hypertens, 24, pp.214~215 (2006)
  6. Childs BG, "Cellular senescence in aging and age-related disease : from mechanisms to therapy", Nat Med, 21, pp.1424~1435 (2015)
  7. Minamino T, "Endothelial cell senescence in human atherosclerosis : role of telomere in endothelial dysfunction", Circulation, 105, pp.1541~1544 (2002)
  8. Shimizu I, "DNA damage response and metabolic disease", Cell Metab, 20, pp.967~977 (2014)
  9. Baker DJ, "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders", Nature, 479, pp.232~236 (2011)
  10. Karakasilioti I, "DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria", Cell Metab, 18, pp.403~415 (2013)
  11. Sano M, "p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload", Nature, 446, pp.444~448 (2007)
  12. Shimizu I, "p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure", Cell Metab, 15, pp.787~ (2012)
  13. Shimizu I, "Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity", Cell Metab, 18, pp.491~504 (2013)
  14. Tchkonia T, "Cellular senescence and the senescent secretory phenotype : therapeutic opportunities", J Clin Invest, 123, pp.966~972 (2013)
  15. Yokoyama M, "p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia", J Mol Cell Cardiol, 129, pp.105~117 (2019)
  16. Yoshida Y, "p53-induced inflammation exacerbates cardiac dysfunction during pressure overload", J Mol Cell Cardiol, 85, pp.183~198 (2015)
  17. Hayflick L, "The serial cultivation of human diploid cell strains", Exp Cell Res, 25, pp.585~621 (1961)
  18. Shimizu I, "Cellular senescence in cardiac diseases", J Cardiol, 74, pp.313~319 (2019)
  19. Minamino T, "A crucial role for adipose tissue p53 in the regulation of insulin resistance", Nat Med, 15, pp.1082~1087 (2009)
  20. Nelson G, "A senescent cell bystander effect : senescence-induced senescence", Aging Cell, 11, pp.345~349 (2012)
  21. Anderson R, "Length-independent telomere damage drives post-mitotic cardiomyocyte senescence", EMBO J, 38, pp.e100492~ (2019)
  22. Baker DJ, "Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan", Nature, 530, pp.184~189 (2016)
  23. Childs BG, "Senescent intimal foam cells are deleterious at all stages of atherosclerosis", Science, 354, pp.472~477 (2016)
  24. Chang J, "Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice", Nat Med, 22, pp.78~83 (2016)
  25. Cafueri G, "Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition", PLoS One, 7, pp.e35312~ (2012)
  26. Marchand A, "The Wnt", beta-catenin pathway is activated during advanced arterial aging in humans, 2011, pp.10, 220~232
  27. Morgan RG, "Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries", Am J Physiol Heart Circ Physiol, 305, pp.H251~H258 (2013)
  28. Lin JR, "Downregulation of dynamin-related protein 1 contributes to impaired autophagic flux and angiogenic function in senescent endothelial cells", Arterioscler Thromb Vasc Biol, 35, pp.1413~1422 (2015)
  29. Melk A, "Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney", Kidney Int, 65, pp.510~520 (2004)
  30. Rajapakse AG, "Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging : inhibition by resveratrol", PLoS One, 6, pp.e19237~ (2011)
  31. Yang D, "Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence", Aging Cell, 6, pp.257~260 (2007)
  32. Telomeres Mendelian Randomization Collaboration, "Association between telomere length and risk of cancer and non-neoplastic diseases : a mendelian randomization study", JAMA Oncol, 3, pp.636~651 (2017)
  33. Riches K, "Progressive development of aberrant smooth muscle cell phenotype in abdominal aortic aneurysm disease", J Vasc Res, 55, pp.35~46 (2018)
  34. Imai SI, "It takes two to tango : NAD+ and sirtuins in aging", longevity control, 2016, pp.2, 16017~
  35. Chen HZ, "Age-associated sirtuin 1 reduction in vascular smooth muscle links vascular senescence and inflammation to abdominal aortic aneurysm", Circ Res, 119, pp.1076~1088 (2016)
  36. Bordone L, "Calorie restriction, SIRT1 and metabolism : understanding longevity", Nat Rev Mol Cell Biol, 6, pp.298~305 (2005)
  37. Guarente L, "Calorie restriction--the SIR2 connection", Cell, 120, pp.473~482 (2005)
  38. Liu Y, "Calorie restriction protects against experimental abdominal aortic aneurysms in mice", J Exp Med, 213, pp.2473~2488 (2016)
  39. Gao P, "Caloric restriction exacerbates angiotensin II-induced abdominal aortic aneurysm in the absence of p53", Hypertension, 73, pp.547~560 (2019)
  40. Zhang WM, "Sustained activation of ADP", P2ry12 signaling induces SMC senescence contributing to thoracic aortic aneurysm, J Mol Cell Cardiol, pp.2016, 99[DOI]
  41. Satoh M, "Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease", Atherosclerosis, 198, pp.347~353 (2008)
  42. Hammadah M, "Telomere shortening, regenerative capacity, and cardiovascular outcomes", Circ Res, 120, pp.1130~1138 (2017)
  43. Salpea KD, "Telomere length in atherosclerosis and diabetes", Atherosclerosis, 209, pp.35~38 (2010)
  44. Haycock PC, "Leucocyte telomere length and risk of cardiovascular disease : systematic review and meta-analysis", BMJ, 349, pp.g4227~ (2014)
  45. Mori MA, "Extracellular miRNAs : from biomarkers to mediators of physiology and disease", Cell Metab, 30, pp.656~673 (2019)
  46. Salem ES, "RNAs and RNA-binding proteins in immuno-metabolic homeostasis and diseases", Front Cardiovasc Med, 6, pp.106~ (2019)
  47. Nasu T, "Expression of miR-23a induces leukocyte telomere shortening and is associated with poor clinical outcomes in patients with coronary artery disease", Eur Heart J, 38, pp.ehx501~ (2017)
  48. Shimizu I, "Vascular rarefaction mediates whitening of brown fat in obesity", J Clin Invest, 124, pp.2099~2112 (2014)
  49. Harper SJ, "VEGF-A splicing : the key to anti-angiogenic therapeutics?", Nat Rev Cancer, 8, pp.880~887 (2008)
  50. Kikuchi R, "An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease", Nat Med, 20, pp.1464~1471 (2014)
  51. Latorre E, "The VEGFA156b isoform is dysregulated in senescent endothelial cells and may be associated with prevalent and incident coronary heart disease", Clin Sci(Lond), 132, pp.313~325 (2018)
  52. Guirguis-Blake JM, "Screening for peripheral artery disease using the ankle-brachial index : updated evidence report and systematic review for the US preventive services task force", JAMA, 320, pp.184~196 (2018)
  53. Oberdier MT, "Subclinical longitudinal change in ankle-brachial index with aging in a community-dwelling population is associated with central arterial stiffening", J Am Heart Assoc, 8, pp.e011650~ (2019)
  54. Olinic DM, "Epidemiology of peripheral artery disease in Europe : VAS educational paper", Int Angiol, 37, pp.327~334 (2018)
  55. Faber JE, "Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues", Arterioscler Thromb Vasc Biol, 31, pp.1748~1756 (2011)
  56. Paradis S, "Aging exacerbates ischemia-reperfusion-induced mitochondrial respiration impairment in skeletal muscle", Antioxidants(Basel), 8, pp.E168~ (2019)
  57. Kokubun T, "Telomerase plays a pivotal role in collateral growth under ischemia by suppressing age-induced oxidative stress, expression of p53, and pro-apoptotic proteins", Int Heart J, 60, pp.736~745 (2019)
  58. Sosińska-Zawierucha P, "Sulodexide slows down the senescence of aortic endothelial cells exposed to serum from patients with peripheral artery diseases", Cell Physiol Biochem, 45, pp.2225~2232 (2018)
  59. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
  60. Libby P, "Progress and challenges in translating the biology of atherosclerosis", Nature, 473, pp.317~325 (2011)
  61. Matthews C, "Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis : effects of telomerase and oxidative stress", Circ Res, 99, pp.156~164 (2006)
  62. Faggiotto A, "Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation", Arteriosclerosis, 4, pp.323~340 (1984)
  63. Wang YC, "Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo", Aging Cell, 17, pp.e12792~ (2018)
  64. de Lange T, "Protection of mammalian telomeres", Oncogene, 21, pp.532~540 (2002)
  65. Wang J, "Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability", Circulation, 132, pp.1909~1919 (2015)
  66. Reaux A, "Angiotensin III : a central regulator of vasopressin release and blood pressure", Trends Endocrinol Metab, 12, pp.157~162 (2001)
  67. Kunieda T, "Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway", Circulation, 114, pp.953~960 (2006)
  68. Miao SB, "Accumulation of smooth muscle 22α protein accelerates senescence of vascular smooth muscle cells via stabilization of p53 in vitro and in vivo", Arterioscler Thromb Vasc Biol, 37, pp.1849~1859 (2017)
  69. Gardner SE, "Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype", Atherosclerosis, 244, pp.E5~ (2016)
  70. Colman RJ, "Caloric restriction delays disease onset and mortality in rhesus monkeys", Science, 325, pp.201~204 (2009)
  71. Yoshino J, "NAD+ intermediates : the biology and therapeutic potential of NMN and NR", Cell Metab, 27, pp.513~528 (2018)
  72. Watson A, "Nicotinamide phosphoribosyltransferase in smooth muscle cells maintains genome integrity, resists aortic medial degeneration, and is suppressed in human thoracic aortic aneurysm disease", Circ Res, 120, pp.1889~1902 (2017)
  73. Katsuumi G, "Vascular senescence in cardiovascular and metabolic diseases", Front Cardiovasc Med, 5, pp.18~ (2018)
  74. Torella D, "Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury", Am J Physiol Heart Circ Physiol, 287, pp.H2850~H2860 (2004)
  75. Yokoyama M, "Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity", Cell Reports, 7, pp.1691~1703 (2014)
  76. Warboys CM, "Disturbed flow promotes endothelial senescence via a p53-dependent pathway", Arterioscler Thromb Vasc Biol, 34, pp.985~995 (2014)
  77. Steinberg D, "Clinical trials of antioxidants in atherosclerosis : are we doing the right thing?", Lancet, 346, pp.36~38 (1995)
  78. Hofmann P, "Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling", Cardiovasc Res, 115, pp.230~242 (2019)
  79. Furuuchi R, "Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health", PLoS One, 13, pp.e0202051~ (2018)
  80. Tsuboi T, "Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence", PLoS One, 13, pp.e0192252~ (2018)
  81. Sakai C, "Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells", PLoS One, 12, pp.e0187934~ (2017)
  82. Lesniewski LA, "Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways", Aging Cell, 16, pp.17~26 (2017)
  83. Sjøberg KA, "Exercise increases human skeletal muscle insulin sensitivity via coordinated increases in microvascular perfusion and molecular signaling", Diabetes, 66, pp.1501~1510 (2017)
  84. Ji LL, "Redox signaling in skeletal muscle : role of aging and exercise", Adv Physiol Educ, 39, pp.352~359 (2015)
  85. Nyberg M, "Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans", J Physiol, 590, pp.5361~5370 (2012)
  86. Reid MB, "Generation of reactive oxygen and nitrogen species in contracting skeletal muscle : potential impact on aging", Ann N Y Acad Sci, 959, pp.108~116 (2002)
  87. Sindler AL, "Age and exercise training alter signaling through reactive oxygen species in the endothelium of skeletal muscle arterioles", J Appl Physiol(1985), 114, pp.681~693 (2013)
  88. Rossman MJ, "Endothelial cell senescence with aging in healthy humans : prevention by habitual exercise and relation to vascular endothelial function", Am J Physiol Heart Circ Physiol, 313, pp.H890~H895 (2017)
  89. Calvert PA, "Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity", Arterioscler Thromb Vasc Biol, 31, pp.2157~2164 (2011)
  90. Cawthon RM, "Association between telomere length in blood and mortality in people aged 60 years or older", Lancet, 361, pp.393~395 (2003)
  91. Cudejko C, "p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages", Blood, 118, pp.2556~2566 (2011)
  92. Hickson LJ, "Senolytics decrease senescent cells in humans : preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease", EBioMedicine, 47, pp.446~456 (2019)
  93. Roos CM, "Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice", Aging Cell, 15, pp.973~977 (2016)
  94. Zhu Y, "The Achilles' heel of senescent cells : from transcriptome to senolytic drugs", Aging Cell, 14, pp.644~658 (2015)
  95. Lewis-McDougall FC, "Aged-senescent cells contribute to impaired heart regeneration", Aging Cell, 18, pp.e12931~ (2019)
  96. Walaszczyk A, "Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction", Aging Cell, 18, pp.e12945~ (2019)
  97. Hartmann JT, "Tyrosine kinase inhibitors-a review on pharmacology, metabolism and side effects", Curr Drug Metab, 10, pp.470~481 (2009)
  98. Wilson WH, "Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies : a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity", Lancet Oncol, 11, pp.1149~1159 (2010)

관련 논문AI추천

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeun생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Senotherapeutics: emerging strategy for healthy aging and age-related disease김억천, 김재룡생화학분자생물학회 · BMB Reports2019 · 제52권 제1호Hallmarks of cellular senescence: biology, mechanisms, regulationsAjoolabady Amir, Bahijri Suhad, Pratico Domenico, Ren Jun, Tuomilehto Jaakko, Uversky Vladimir N.생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes김정민, 변해옥, 윤계순, 이영경생화학분자생물학회 · BMB Reports2015 · 제48권 제10호Cellular senescence, aging, and age-related disease: Special issue of BMB Reports in 2019이재선생화학분자생물학회 · BMB Reports2019 · 제52권 제1호Cellular senescence: a promising strategy for cancer therapy이성주, 이재선생화학분자생물학회 · BMB Reports2019 · 제52권 제1호

이 간행물의 다른 논문 (15건)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence김규, 이상학pp. 1-7mTOR-coordinated Post-Transcriptional Gene Regulations: from Fundamental to Pathogenic Insights용정식, Hsin-Sung Yehpp. 8-22Sphingolipid Mediators of Myocardial PathologyAnna Kovilakath, L. Ashley Cowartpp. 23-49Ceramides: Nutrient Signals that Drive HepatosteatosisScott A. Summerspp. 50-65CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac DysfunctionJan F.C. Glatz, Joost J.F.P. Luiken, Miranda Nabbenpp. 66-78
원문 보기